Qingdao Jiulong Biopharma Group is a private pharmaceutical enterprise group with 32 years of entrepreneurial history, integrating scientific research, production and sales with a complete industrial chain from initial raw materials to high-quality raw materials to preparations, from China to the world.

　　In August 2008, heparin sodium was approved by FDA. In March 2015, heparin sodium API Workshop I and Workshop II zero "483" (i.e. zero defect item) passed the re-certification and certification of FDA.

　　Qingdao Jiulong Biopharmaceuticals Group's product raw material procurement channels are formal and legal, raw material quality is good, the production link is strictly controlled, the product quality is high, safe and effective.

　　The products of Qingdao Jiulao Biopharmaceutical Group are exported to Europe, America, the Middle East, Southeast Asia and other markets. In 2012, the export volume of heparin sodium high-quality apis was the third largest in China, and the largest manufacturer in the United States.

　　Qingdao Jiulong Group is a heparin manufacturer,Chondroitin Sulfate Sodium manufacturer and heparin sodium API supplier. Production of heparin sodium, enoxaparin sodium, heparinoid, dalteparin sodium,chondroitin sulfate and so on. Welcome to consult heparin sodium price!